Kim Sooyoung, Sarkar Rajiv, Kumar Sampath, Lewis Melissa Glenda, Tozan Yesim, Albert Sandra
Department of Public Health Policy and Management, School of Global Public Health, New York University, New York, New York, United States of America.
Indian Institute of Public Health Shillong, Pasteur Hill, Shillong, Meghalaya, India.
PLOS Glob Public Health. 2024 Feb 27;4(2):e0002250. doi: 10.1371/journal.pgph.0002250. eCollection 2024.
Meghalaya, a state in the northeastern region of India, had a markedly low vaccine uptake compared to the other states in the country when COVID-19 vaccines were being rolled out in 2021. This study aimed to characterize the distinct vaccine-hesitant subpopulations in healthcare and community settings in Meghalaya state in the early days of the vaccination program. We used data from a cross-sectional survey that was administered to 200 healthcare workers (HCWs) and 200 community members, who were a priori identified as 'vaccine-eligible' and 'vaccine-hesitant,' in Shillong city, Meghalaya, in May 2021. The questionnaire collected information on participants' sociodemographic characteristics, COVID-19 history, and presence of medical comorbidities. Participants were also asked to provide a dichotomous answer to a set of 19 questions, probing the reasons for their hesitancy towards COVID-19 vaccines. A multiple correspondence analysis, followed by an agglomerative hierarchical cluster analysis, was performed to identify the distinct clusters of vaccine-hesitant participants. We identified seven clusters: indecisive HCWs (n = 71), HCWs skeptical of COVID-19 and COVID-19 vaccines (n = 128), highly educated male tribal/clan leaders concerned about infertility and future pregnancies (n = 14), less educated adults influenced by leaders and family (n = 47), older adults worried about vaccine safety (n = 76), middle-aged adults without young children (n = 56), and highly educated ethnic/religious minorities with misinformation (n = 8). Across all the clusters, perceived logistical challenges associated with receiving the vaccine was identified as a common factor contributing to vaccine hesitancy. Our study findings provide valuable insights for local and state health authorities to effectively target distinct subgroups of vaccine-hesitant populations with tailored health messaging, and also call for a comprehensive approach to address the common drivers of vaccine hesitancy in communities with low vaccination rates.
梅加拉亚邦是印度东北部的一个邦,在2021年新冠疫苗推出期间,与该国其他邦相比,其疫苗接种率明显较低。本研究旨在描述疫苗接种计划初期梅加拉亚邦医疗保健和社区环境中不同的疫苗犹豫亚群体特征。我们使用了2021年5月在梅加拉亚邦西隆市对200名医护人员和200名社区成员进行的横断面调查数据,这些人被预先确定为“符合疫苗接种条件”和“对疫苗犹豫”。问卷收集了参与者的社会人口特征、新冠病史和合并症情况。参与者还被要求对一组19个问题给出二分法答案,以探究他们对新冠疫苗犹豫的原因。进行了多重对应分析,随后进行凝聚层次聚类分析,以识别对疫苗犹豫的参与者的不同聚类。我们识别出了七个聚类:犹豫不决的医护人员(n = 71)、对新冠病毒和新冠疫苗持怀疑态度的医护人员(n = 128)、担心不孕和未来怀孕的受过高等教育的男性部落/氏族领袖(n = 14)、受领袖和家庭影响的受教育程度较低的成年人(n = 47)、担心疫苗安全的老年人(n = 76)、没有年幼子女的中年成年人(n = 56)以及收到错误信息的受过高等教育的少数族裔/宗教少数群体(n = 8)。在所有聚类中,与接种疫苗相关的后勤挑战被确定为导致疫苗犹豫的一个共同因素。我们的研究结果为地方和邦卫生当局提供了宝贵的见解,以便通过量身定制的健康信息有效地针对不同的疫苗犹豫人群亚组,同时也呼吁采取综合方法来解决疫苗接种率低的社区中疫苗犹豫的共同驱动因素。